中新网上海5月25日电（记者陈静）25日，在中国首届CELLplus学术论坛、细胞应激医学交叉研讨会上，同济大学癌症中心正式挂牌成立，标志着同济大学附属第十人民医院在肿瘤精准诊疗领域迈出了重要一步。
同济大学癌症中心的成立，旨在集合多学科力量，开展肿瘤精准诊疗的科研与临床工作。该中心将依托同济大学在生命科学、医学领域的深厚学术背景，以及第十人民医院在肿瘤治疗方面的丰富经验，致力于打造国际知名的肿瘤精准诊疗中心。
中心成立后，将重点开展肿瘤细胞应激机制研究，推动细胞治疗新技术的发展，并探索个性化治疗方案。此外，中心还将加强与国内外科研机构的合作，引进先进的诊疗技术和设备，提升肿瘤精准诊疗水平。
同济大学癌症中心的成立，不仅将为患者提供更加精准、有效的治疗方案，也将为科研人员提供一个开放、合作的平台，共同推动肿瘤治疗领域的进步。
英语如下：
Title: “Founded: Tongji University Cancer Center Focuses on Establishing a Global Hub for Precision Oncology”
Keywords: Cancer Center, Precision Oncology, Tongji University
News Content:
SHANGHAI, May 25 (Xinhua) — Tongji University Cancer Center was officially launched at the inaugural CELLplus Academic Forum and Cross-disciplinary Symposium on Cell Stress Medicine on Monday, marking a significant step forward in the field of precision oncology for the Tenth People’s Hospital Affiliated to Tongji University.
The establishment of the cancer center aims to pool interdisciplinary strengths for research and clinical work in precision oncology. It will leverage the profound academic background of Tongji University in life sciences and medicine, as well as the rich experience of the Tenth People’s Hospital in cancer treatment, to build an internationally renowned center for precision oncology.
After its establishment, the center will focus on researching the mechanisms of tumor cell stress, promoting the development of novel cell therapy technologies, and exploring personalized treatment plans. In addition, the center will strengthen cooperation with research institutions both domestically and internationally,引进先进的诊疗技术和设备, and enhance the level of precision oncology treatment.
The launch of the Tongji University Cancer Center not only aims to provide patients with more precise and effective treatment options but also serves as an open and collaborative platform for researchers to jointly drive progress in the field of cancer treatment.
【来源】http://www.chinanews.com/life/2024/05-25/10223214.shtml
Views: 2